ACC	American College of Cardiology
AHA	American Heart Association
ASCO	American Society of Clinical Oncology
ASH	American Society of Hematology
BP	Blood pressure
BRAF	B-Rapid Accelerating Fibrosarcoma gene
CD	Cluster of Differentiation
CVD	Cardiovascular Disease
CTCAE	Common Terminology Criteria for Adverse Events
CVD	Cardiovascular Disease
CUP	Cancer of Unknown Primary
DNA	de-oxyribonucleic acid
ET-1	Endothelian-1
ESA	Erythropoeisis Stimulating Agents
ESC	European Society of Cardiology
HER2	Human Epidural Growth Factor Receptor 2
HMOD	Hypertension-Mediated Organ Damage
LVD	Left Ventricular Dysfunction
LVSD	Left Ventricular Systolic Dysfunction
MACE	Major Adverse Cardiovascular Event
MEK	Mitogen extracellular signal-regulated kinase
mTOR	mammalian Target of Rapamycin
NCI	National Cancer Institute
NO	Nitric Oxide
NSAID	Non-steroidal anti-inflammatory drug
PDGFR	Plate derived growth factor receptor
RAS	Renin Angiotensin System
RNA	ribonucleic acid
SPRINT	Systolic Blood Pressure Intervention Trial
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analysis
TKI	Tyrosine Kinase Inhibitors
VEGF	Vascular Endothelial Growth Factor